Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells

In recent years, studies with plant compounds have shown both chemotherapeutic and chemopreventive properties. The current study with plant stress hormones (jasmonates) showed growth inhibitory effects in breast cancer cells. Cis-jasmone (CJ) and methyl jasmonate (MJ) inhibited the long-term prolife...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anti-cancer drugs 2008-09, Vol.19 (8), p.766-776
Hauptverfasser: Yeruva, Laxmi, Elegbede, J. Abiodun, Carper, Stephen W.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 776
container_issue 8
container_start_page 766
container_title Anti-cancer drugs
container_volume 19
creator Yeruva, Laxmi
Elegbede, J. Abiodun
Carper, Stephen W.
description In recent years, studies with plant compounds have shown both chemotherapeutic and chemopreventive properties. The current study with plant stress hormones (jasmonates) showed growth inhibitory effects in breast cancer cells. Cis-jasmone (CJ) and methyl jasmonate (MJ) inhibited the long-term proliferation of MDA-MB-435 and MCF-7 cells. Cell cycle analysis showed G0/G1 and S-phase arrest with increasing apoptotic population. Cellular signaling studies with MJ showed decreased membrane fluidity and activation of extrinsic and intrinsic apoptotic pathways. Specifically in extrinsic apoptotic pathway increased expression of TNFR1, activation of MAPK and caspase-8 was observed. MJ also decreased the mitochondrial membrane potential and activated caspase-3 in breast cancer cells. In conclusion our results revealed novel signaling mechanism of MJ in breast cancer cells, indicating that MJ could have potential applications for chemotherapeutic purposes.
doi_str_mv 10.1097/CAD.0b013e32830b5894
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2745996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_2745996</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_27459963</originalsourceid><addsrcrecordid>eNqljD1PwzAYhC0EouHjHzD4D6TYdVLHCxIqVCxs7NEb5w115Y_Idipl4beTIhZmprt7TneEPHC25kzJx93zy5p1jAsUm0awrm5UdUEKXklR1rLil6RgqlZlpaRYkZuUjoyxhYtrsuLNVjHWyIJ8vWM-zJYeIbngISPtUUeEhIk6dF0Ej3Swk-lNnin4nhrfT3ppYQxjDskkejJA8-RCpH7Z_qABdF5yRI3j2fBlRrvzb6YavMZINVqb7sjVADbh_a_ekqf968furRynzmGv0ecIth2jcRDnNoBp_zbeHNrPcGo3sqqV2op_H3wDvNxxkw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells</title><source>Journals@Ovid Complete</source><creator>Yeruva, Laxmi ; Elegbede, J. Abiodun ; Carper, Stephen W.</creator><creatorcontrib>Yeruva, Laxmi ; Elegbede, J. Abiodun ; Carper, Stephen W.</creatorcontrib><description>In recent years, studies with plant compounds have shown both chemotherapeutic and chemopreventive properties. The current study with plant stress hormones (jasmonates) showed growth inhibitory effects in breast cancer cells. Cis-jasmone (CJ) and methyl jasmonate (MJ) inhibited the long-term proliferation of MDA-MB-435 and MCF-7 cells. Cell cycle analysis showed G0/G1 and S-phase arrest with increasing apoptotic population. Cellular signaling studies with MJ showed decreased membrane fluidity and activation of extrinsic and intrinsic apoptotic pathways. Specifically in extrinsic apoptotic pathway increased expression of TNFR1, activation of MAPK and caspase-8 was observed. MJ also decreased the mitochondrial membrane potential and activated caspase-3 in breast cancer cells. In conclusion our results revealed novel signaling mechanism of MJ in breast cancer cells, indicating that MJ could have potential applications for chemotherapeutic purposes.</description><identifier>ISSN: 0959-4973</identifier><identifier>EISSN: 1473-5741</identifier><identifier>DOI: 10.1097/CAD.0b013e32830b5894</identifier><identifier>PMID: 18690087</identifier><language>eng</language><ispartof>Anti-cancer drugs, 2008-09, Vol.19 (8), p.766-776</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Yeruva, Laxmi</creatorcontrib><creatorcontrib>Elegbede, J. Abiodun</creatorcontrib><creatorcontrib>Carper, Stephen W.</creatorcontrib><title>Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells</title><title>Anti-cancer drugs</title><description>In recent years, studies with plant compounds have shown both chemotherapeutic and chemopreventive properties. The current study with plant stress hormones (jasmonates) showed growth inhibitory effects in breast cancer cells. Cis-jasmone (CJ) and methyl jasmonate (MJ) inhibited the long-term proliferation of MDA-MB-435 and MCF-7 cells. Cell cycle analysis showed G0/G1 and S-phase arrest with increasing apoptotic population. Cellular signaling studies with MJ showed decreased membrane fluidity and activation of extrinsic and intrinsic apoptotic pathways. Specifically in extrinsic apoptotic pathway increased expression of TNFR1, activation of MAPK and caspase-8 was observed. MJ also decreased the mitochondrial membrane potential and activated caspase-3 in breast cancer cells. In conclusion our results revealed novel signaling mechanism of MJ in breast cancer cells, indicating that MJ could have potential applications for chemotherapeutic purposes.</description><issn>0959-4973</issn><issn>1473-5741</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqljD1PwzAYhC0EouHjHzD4D6TYdVLHCxIqVCxs7NEb5w115Y_Idipl4beTIhZmprt7TneEPHC25kzJx93zy5p1jAsUm0awrm5UdUEKXklR1rLil6RgqlZlpaRYkZuUjoyxhYtrsuLNVjHWyIJ8vWM-zJYeIbngISPtUUeEhIk6dF0Ej3Swk-lNnin4nhrfT3ppYQxjDskkejJA8-RCpH7Z_qABdF5yRI3j2fBlRrvzb6YavMZINVqb7sjVADbh_a_ekqf968furRynzmGv0ecIth2jcRDnNoBp_zbeHNrPcGo3sqqV2op_H3wDvNxxkw</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Yeruva, Laxmi</creator><creator>Elegbede, J. Abiodun</creator><creator>Carper, Stephen W.</creator><scope>5PM</scope></search><sort><creationdate>20080901</creationdate><title>Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells</title><author>Yeruva, Laxmi ; Elegbede, J. Abiodun ; Carper, Stephen W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_27459963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeruva, Laxmi</creatorcontrib><creatorcontrib>Elegbede, J. Abiodun</creatorcontrib><creatorcontrib>Carper, Stephen W.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Anti-cancer drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeruva, Laxmi</au><au>Elegbede, J. Abiodun</au><au>Carper, Stephen W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells</atitle><jtitle>Anti-cancer drugs</jtitle><date>2008-09-01</date><risdate>2008</risdate><volume>19</volume><issue>8</issue><spage>766</spage><epage>776</epage><pages>766-776</pages><issn>0959-4973</issn><eissn>1473-5741</eissn><abstract>In recent years, studies with plant compounds have shown both chemotherapeutic and chemopreventive properties. The current study with plant stress hormones (jasmonates) showed growth inhibitory effects in breast cancer cells. Cis-jasmone (CJ) and methyl jasmonate (MJ) inhibited the long-term proliferation of MDA-MB-435 and MCF-7 cells. Cell cycle analysis showed G0/G1 and S-phase arrest with increasing apoptotic population. Cellular signaling studies with MJ showed decreased membrane fluidity and activation of extrinsic and intrinsic apoptotic pathways. Specifically in extrinsic apoptotic pathway increased expression of TNFR1, activation of MAPK and caspase-8 was observed. MJ also decreased the mitochondrial membrane potential and activated caspase-3 in breast cancer cells. In conclusion our results revealed novel signaling mechanism of MJ in breast cancer cells, indicating that MJ could have potential applications for chemotherapeutic purposes.</abstract><pmid>18690087</pmid><doi>10.1097/CAD.0b013e32830b5894</doi></addata></record>
fulltext fulltext
identifier ISSN: 0959-4973
ispartof Anti-cancer drugs, 2008-09, Vol.19 (8), p.766-776
issn 0959-4973
1473-5741
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2745996
source Journals@Ovid Complete
title Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A28%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methyl%20jasmonate%20decreases%20membrane%20fluidity%20and%20induces%20apoptosis%20via%20tumor%20necrosis%20factor%20receptor%201%20in%20breast%20cancer%20cells&rft.jtitle=Anti-cancer%20drugs&rft.au=Yeruva,%20Laxmi&rft.date=2008-09-01&rft.volume=19&rft.issue=8&rft.spage=766&rft.epage=776&rft.pages=766-776&rft.issn=0959-4973&rft.eissn=1473-5741&rft_id=info:doi/10.1097/CAD.0b013e32830b5894&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_2745996%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18690087&rfr_iscdi=true